GMOD yields 0.92% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, GMOD + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GMOD + MRK for your $10,000?
GMOD seeks positive total return through a dynamic, multi-asset allocation approach that adjusts exposures across equities, fixed income, and liquid alternative strategies based on GMOs long-term valuation and risk outlook. The fund typically operates as a fund of funds, investing mainly in other GMO-managed and third-party vehicles but may also hold securities directly. Allocation decisions are guided by GMOs forecasts of expected returns and its view that valuations tend to revert to fair value over time. This forward-looking process incorporates assessments of relative risk, economic trends, and market conditions to determine where capital is best positioned. The portfolios flexibility allows allocations to shift meaningfully, with equity exposure generally ranging between 40% and 80% of net assets. While diversified across asset classes, the fund can concentrate in certain markets or sectors when valuation signals support a higher conviction stance.
Full GMOD Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.